PT-141 is supplied for laboratory research workflows that require clear product identity, careful handling, and documented specifications.
Research use only. Not for human or veterinary consumption, diagnosis, or treatment.
Weight
0.05 lbs
📊 Research Dosages and Protocols
Research phase
Research dosage
Administration frequency
Starting / Adaptation
0.5 mg
As needed
Primary / Maintenance
1.0 - 1.5 mg
As needed
Maximum exposure
2.0 mg
As needed
* Note: The listed dosages are based on reference research models and should be adapted to the specific requirements of your laboratory protocol.
🧫 Reconstitution and Storage
Reconstitution: Bacteriostatic Water (BAC Water) is recommended. Add it slowly down the side of the vial. Gently swirl the vial without shaking aggressively.
Storage (lyophilized powder): Store in a dark place at -20°C to 4°C.
Storage (reconstituted): After reconstitution, refrigerate at 2°C to 8°C and use within 20–30 days.
🔬 Clinical Study Results
PT-141 (bremelanotide) acts through melanocortin receptors in the central nervous system:
Sexual desire: Unlike peripheral vasodilators, PT-141 acts centrally and has been studied for sexual desire and arousal in men and women.
Erectile function: Clinical studies have reported improved erectile function, including in some participants who did not respond to PDE5 inhibitors.
* Sold for laboratory research and in vitro models only. The information above summarizes findings reported in published medical literature and human clinical studies.
Frequently asked questions will be added before launch.
